SABS SAB Biotherapeutics, Inc Year-over-year net earnings per share growth for the last 12 months
Could geopolitical risks and raw material supply disruptions impact the revenues of SAB Biotherapeutics (SABS)? This chart from the GURU.Markets platform provides the answer, where the quarterly EPS growth rate shows a metric value of -12.70. The company's growth relies on the DiversitAb platform and successes in diabetes treatment, while the long-term expansion of the immunotherapy market ensures sustainable demand from the medical sector.
Summary analytical data breakdowns for SAB Biotherapeutics Inc (SABS)
- market value and analyst target forecast:
- market capitalization data:
- book capitalization indicators:
- debt and liquidity data:
Debt to Equity SAB Biotherapeutics|SABS - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital SAB Biotherapeutics|SABS - Company Aggregate Debts|Debts to Book Capitalization SAB Biotherapeutics, Inc|SABS - Company Long-Term Debt|Company Current Liabilities SAB Biotherapeutics|Quick Ratio sabbiotherapeutics.com
- earnings and market multiples details:
SABS - Company Net Income|Projected Future Earnings SAB Biotherapeutics|SABS - Business Payback Period|Future Price to Earnings SAB Biotherapeutics, Inc|SABS - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio SAB Biotherapeutics, Inc|SABS - Company profit before taxes, interest and amortization|Net earnings per share (EPS TTM) SAB Biotherapeutics|SABS - Earnings per share for the trailing year|Quarterly EPS earnings growth sabbiotherapeutics.com|SABS - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year SAB Biotherapeutics
- company sales and revenue statistics:
Initial company analysis:SAB Biotherapeutics, Inc. - SABS
Quarterly EPS dynamics measure the rate of change in net income per share, allowing for an assessment of business resilience to market shocks through a mathematically rigorous difference between reporting periods. Amid the expansion of the immunotherapy market for SAB Biotherapeutics (SABS), the comparison of quarterly EPS demonstrates the effectiveness of monetizing high demand for biologics, separating real financial growth from speculative investor expectations.
Direct competitors
argenx (ARGX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months BioNTech Inc.|Year-over-year net earnings per share growth for the last 12 months ABVX|Quarterly EPS earnings growth ADMA Corp|Year-over-year earnings per share growth for the last twelve months Protagonist Therapeutics (PTGX)|immunovant.com - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth KNSA (Kiniksa)|Grifols SA (GRFS) - Earnings per share growth in annualized terms for the last twelve months|ADPT - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Celldex Corp CLDX|AUPH: Quarterly EPS earnings growth|biocryst.com (BCRX) - Quarterly EPS earnings growth|VERA (Vera Therapeutics) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months DNTH|Year-over-year net earnings per share growth for the last 12 months PHVS (Pharvaris Corp)|ABCL (AbCellera Bio) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth TRML (Tourmaline Bio, Inc.)|precigen.com - Year-over-year earnings per share growth for the last twelve months|Pharming Group - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Nektar Therapeutics Inc NKTR|Upstream Bio Corp (UPB) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Zenas Corp (ZBIO)|Year-over-year net earnings per share growth for the last 12 months IMNM|GOSS (gossamerbio.com) - Year-over-year earnings per share growth rate for the last twelve months|Quarterly EPS earnings growth KALV|SEPN (Septerna, Inc.) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth PVLA (Pieris Pharmaceuticals Inc)|Savara Pharma (SVRA) - Earnings per share growth in annualized terms for the last twelve months|RIGL - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months ANAB (anaptysbio.com)|ATXS: Quarterly EPS earnings growth|enGene Holdings Inc (ENGN) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months RAPT Therapeutics|Aerovate - Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth ACRS|KYTX - Earnings per share growth in annualized terms for the last twelve months|Tiziana Life Sciences Ltd - Year-over-year net earnings per share growth for the last 12 months|Quarterly EPS earnings growth Cabaletta Bio Inc. CABA|VTYX: Year-over-year net earnings per share growth for the last 12 months|Theratechnologies, Inc - Year-over-year earnings per share growth rate for the last twelve months|AVTX: Quarterly EPS earnings growth|ELDN - Year-over-year net earnings per share change for the last twelve months|AGEN (Agenus Inc.) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Climb Bio Inc. (CLYM)|Year-over-year earnings per share growth for the last twelve months Zura Bio (ZURA)|Year-over-year net earnings per share change for the last twelve months aTyr Pharmaceuticals|Year-over-year earnings per share growth for the last twelve months Adagene Inc. ADAG|Year-over-year net earnings per share change for the last twelve months ImageneBio (IMA)|Shattuck Therapeutics - Quarterly EPS earnings growth|EQ - Quarterly EPS earnings growth|CNTB: Quarterly EPS earnings growth|IMUX (Immunic) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last twelve months Atara Biotherapeutics, Inc.|InflaRx GmbH (IFRX) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months X4 Pharmaceuticals, Inc. (XFOR)|ACET: Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth CELU (Celularity)|Year-over-year earnings per one share growth for the last 12 months INMB|Barinthus Biotherapeutics - Quarterly EPS earnings growth|KZR - Quarterly EPS earnings growth|Akari Therapeutics Plc (AKTX) - Year-over-year earnings per share growth for the last twelve months|Enlivex Therapeutics Ltd. - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Q32 Bio Inc|Year-over-year net earnings per share growth for the last 12 months GeoVax Corp (GOVX)|Quarterly EPS earnings growth EDSA|Quarterly EPS earnings growth ibioinc.com (IBIO)|Carisma Therapeutics Inc. - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months XTLB|Bolt Bio - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months HCW Biologics Inc. HCWB|aptevotherapeutics.com (APVO) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months aimimmuno.com|Year-over-year earnings per share growth for the last twelve months Aditxt Inc.|Year-over-year net earnings per share growth for the last 12 months GRI Bio Inc (GRI)|Year-over-year net earnings per share growth for the last 12 months XRTX (XORTX)|Quarterly EPS earnings growth Vyome Therapeutics (HIND)|Year-over-year earnings per share growth for the last twelve months Revelation Biosciences REVB|INDP: Year-over-year earnings per share growth for the last 12 months|Scinai Immunotherapeutics Ltd. - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months CalciMedica, Inc.|affimed.com (AFMD) - Year-over-year earnings per share growth for the last twelve months|ALLK - Year-over-year net earnings per share change for the last twelve months|HOOK (HOOKIPA Pharma, Inc.) - Quarterly EPS earnings growth|Quarterly EPS earnings growth IGM Bio|Quarterly EPS earnings growth ITOS|Year-over-year earnings per share growth for the last twelve months OCEA (Ocean Biomedical Inc)|TC BioPharm (Holdings) PLC - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months THRD
